By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Mologen AG 

P.O. Box 332140

Berlin    D - 14180  Germany
Phone: 49-0-30-857-576-0 Fax: 49-0-30-857-576-50



Gene Therapy

Company News
Dr. Mariola Söhngen Appointed As New CEO Of Mologen AG (MOLGF.PK) 7/23/2015 10:57:52 AM
Mologen AG (MOLGF.PK) Presented Poster At ESMO WCGI 2015 7/6/2015 11:47:13 AM
The Chairman Of The Supervisory Board Of Mologen AG (MOLGF.PK) Resigns From His Office As Board Member And Chairman And Is Nominated For Re-Election 6/18/2015 12:26:49 PM
Mologen AG (MOLGF.PK): First Patient Enrolled In TEACH Study To Treat HIV Patients With MGN1703 6/3/2015 8:15:55 AM
Mologen AG (MOLGF.PK) To Present Poster At ASCO Annual Meeting 5/27/2015 9:57:44 AM
Mologen AG (MOLGF.PK): Progress In Clinical Trials Sets First Quarter Trend 5/12/2015 8:44:23 AM
Mologen AG (MOLGF.PK): Aarhus University Hospital Initiates MGN1703 Study In HIV Patients 5/8/2015 8:50:09 AM
Mologen AG (MOLGF.PK) Presented Data Supporting The Administration Scheme Of MGN1703 At ITOC-2 Conference 2015 3/30/2015 9:08:25 AM
Mologen AG (MOLGF.PK): Start Of Pivotal Study For Cancer Immunotherapy MGN1703 Influences 2014 Annual Result 3/25/2015 9:56:22 AM
Mologen AG (MOLGF.PK) Presented Subgroup Analysis From IMPACT Study And Design Of Pivotal IMPALA Trial At Gastrointestinal Cancers Symposium 2015 1/19/2015 10:13:03 AM